vs
Side-by-side financial comparison of BeOne Medicines Ltd. (ONC) and UGI CORP (UGI). Click either name above to swap in a different company.
UGI CORP is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× BeOne Medicines Ltd.). UGI CORP runs the higher net margin — 14.4% vs 4.4%, a 9.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 3.9%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-155.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -7.5%).
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.
ONC vs UGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $2.1B |
| Net Profit | $66.5M | $297.0M |
| Gross Margin | 90.5% | — |
| Operating Margin | 12.4% | 22.0% |
| Net Margin | 4.4% | 14.4% |
| Revenue YoY | 32.8% | 3.9% |
| Net Profit YoY | 143.8% | -20.8% |
| EPS (diluted) | $0.05 | $1.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $1.1B | $2.6B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $1.0B | $1.2B | ||
| Q2 24 | $929.2M | $1.4B | ||
| Q1 24 | $751.7M | $2.4B |
| Q4 25 | $66.5M | $297.0M | ||
| Q3 25 | $124.8M | $-13.0M | ||
| Q2 25 | $94.3M | $-163.0M | ||
| Q1 25 | $1.3M | $479.0M | ||
| Q4 24 | $-151.9M | $375.0M | ||
| Q3 24 | $-121.3M | $-273.0M | ||
| Q2 24 | $-120.4M | $-48.0M | ||
| Q1 24 | $-251.2M | $496.0M |
| Q4 25 | 90.5% | — | ||
| Q3 25 | 86.1% | — | ||
| Q2 25 | 87.5% | — | ||
| Q1 25 | 85.2% | — | ||
| Q4 24 | 85.8% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 85.1% | — | ||
| Q1 24 | 83.4% | — |
| Q4 25 | 12.4% | 22.0% | ||
| Q3 25 | 11.5% | 1.1% | ||
| Q2 25 | 6.7% | -6.8% | ||
| Q1 25 | 1.0% | 26.6% | ||
| Q4 24 | -7.0% | 24.5% | ||
| Q3 24 | -12.0% | -20.4% | ||
| Q2 24 | -11.5% | 5.0% | ||
| Q1 24 | -34.8% | 29.7% |
| Q4 25 | 4.4% | 14.4% | ||
| Q3 25 | 8.8% | -1.1% | ||
| Q2 25 | 7.2% | -12.0% | ||
| Q1 25 | 0.1% | 18.2% | ||
| Q4 24 | -13.5% | 18.9% | ||
| Q3 24 | -12.1% | -22.6% | ||
| Q2 24 | -13.0% | -3.6% | ||
| Q1 24 | -33.4% | 20.6% |
| Q4 25 | $0.05 | $1.34 | ||
| Q3 25 | $0.08 | $-0.08 | ||
| Q2 25 | $0.06 | $-0.76 | ||
| Q1 25 | $0.00 | $2.19 | ||
| Q4 24 | $-0.10 | $1.74 | ||
| Q3 24 | $-0.09 | $-1.26 | ||
| Q2 24 | $-0.09 | $-0.23 | ||
| Q1 24 | $-0.19 | $2.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $251.0M |
| Total DebtLower is stronger | $836.4M | $6.0B |
| Stockholders' EquityBook value | $4.4B | $5.0B |
| Total Assets | $8.2B | $15.8B |
| Debt / EquityLower = less leverage | 0.19× | 1.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5B | $251.0M | ||
| Q3 25 | $4.0B | $335.0M | ||
| Q2 25 | $2.8B | $350.0M | ||
| Q1 25 | $2.5B | $426.0M | ||
| Q4 24 | $2.6B | $240.0M | ||
| Q3 24 | $2.7B | $213.0M | ||
| Q2 24 | $2.6B | $183.0M | ||
| Q1 24 | $2.8B | $263.0M |
| Q4 25 | $836.4M | $6.0B | ||
| Q3 25 | — | $6.5B | ||
| Q2 25 | — | $5.7B | ||
| Q1 25 | — | $6.6B | ||
| Q4 24 | — | $6.6B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.3B | ||
| Q1 24 | — | $6.7B |
| Q4 25 | $4.4B | $5.0B | ||
| Q3 25 | $4.1B | $4.8B | ||
| Q2 25 | $3.8B | $4.9B | ||
| Q1 25 | $3.5B | $5.0B | ||
| Q4 24 | $3.3B | $4.6B | ||
| Q3 24 | $3.4B | $4.3B | ||
| Q2 24 | $3.4B | $4.7B | ||
| Q1 24 | $3.4B | $4.8B |
| Q4 25 | $8.2B | $15.8B | ||
| Q3 25 | $7.6B | $15.5B | ||
| Q2 25 | $6.3B | $15.4B | ||
| Q1 25 | $5.8B | $15.7B | ||
| Q4 24 | $5.9B | $15.4B | ||
| Q3 24 | $5.8B | $15.1B | ||
| Q2 24 | $5.7B | $15.1B | ||
| Q1 24 | $5.7B | $15.6B |
| Q4 25 | 0.19× | 1.19× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 1.17× | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.34× | ||
| Q1 24 | — | 1.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $417.3M | $66.0M |
| Free Cash FlowOCF − Capex | $379.8M | $-155.0M |
| FCF MarginFCF / Revenue | 25.4% | -7.5% |
| Capex IntensityCapex / Revenue | 2.5% | 10.7% |
| Cash ConversionOCF / Net Profit | 6.28× | 0.22× |
| TTM Free Cash FlowTrailing 4 quarters | $941.7M | $282.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $417.3M | $66.0M | ||
| Q3 25 | $402.6M | $90.0M | ||
| Q2 25 | $263.6M | $289.0M | ||
| Q1 25 | $44.1M | $684.0M | ||
| Q4 24 | $75.2M | $164.0M | ||
| Q3 24 | $188.4M | $151.0M | ||
| Q2 24 | $-95.6M | $390.0M | ||
| Q1 24 | $-308.6M | $522.0M |
| Q4 25 | $379.8M | $-155.0M | ||
| Q3 25 | $354.5M | $-168.0M | ||
| Q2 25 | $219.8M | $67.0M | ||
| Q1 25 | $-12.3M | $538.0M | ||
| Q4 24 | $-17.3M | $-47.0M | ||
| Q3 24 | $54.7M | $-115.0M | ||
| Q2 24 | $-205.5M | $185.0M | ||
| Q1 24 | $-465.1M | $353.0M |
| Q4 25 | 25.4% | -7.5% | ||
| Q3 25 | 25.1% | -14.4% | ||
| Q2 25 | 16.7% | 4.9% | ||
| Q1 25 | -1.1% | 20.4% | ||
| Q4 24 | -1.5% | -2.4% | ||
| Q3 24 | 5.5% | -9.5% | ||
| Q2 24 | -22.1% | 13.7% | ||
| Q1 24 | -61.9% | 14.6% |
| Q4 25 | 2.5% | 10.7% | ||
| Q3 25 | 3.4% | 22.1% | ||
| Q2 25 | 3.3% | 16.3% | ||
| Q1 25 | 5.0% | 5.5% | ||
| Q4 24 | 8.2% | 10.6% | ||
| Q3 24 | 13.3% | 22.0% | ||
| Q2 24 | 11.8% | 15.2% | ||
| Q1 24 | 20.8% | 7.0% |
| Q4 25 | 6.28× | 0.22× | ||
| Q3 25 | 3.22× | — | ||
| Q2 25 | 2.79× | — | ||
| Q1 25 | 34.71× | 1.43× | ||
| Q4 24 | — | 0.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
